According to a Phase I study led by researchers at The University of Texas MD Anderson Cancer Center, published today in ...

A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising ...

The field of cancer immunotherapy has achieved remarkable progress, introducing strategies such as immune checkpoint inhibitors and adoptive cell therapies ...

Scientists in southern China have developed a new strategy to fight cancer by forcing tumor cells to "expose themselves" to ...

With cold and flu season in full swing, people are still headed out to get vaccines. But if you have a chronic illness, which ...

A research team led by Professor Chen Peng from the College of Chemistry and Molecular Engineering at Peking University has ...

Your dermatologist or oncologist may have told you what type of advanced squamous cell carcinoma you have. Here’s what each type means: Locally advanced squamous cell carcinoma: This means cancer has ...

Immunotherapy is offering new hope for cancers that once had grim prognoses by harnessing the body's own immune system to ...

Probiotics are microbes that pacify your immune system and prevent the collateral damage from an overactive inflammatory response. Here’s how to put them to work.

Vivere Oncotherapies, a UC Berkeley spin-out developing cancer therapies that activate the immune system to detect and destroy cancer cells in immunologically cold tumors, today announced over $10M in ...

ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, today announced positive results from its ANKTIVA ...

Better treatment options have improved survival rates in the U.S., according to a report from the American Cancer Society.